Coordinate, equimolar secretion of smaller peptide products derived from pro-ACTH/endorphin by mouse pituitary tumor cells by unknown
Coordinate, Equimolar Secretion of Smaller
Peptide Products Derived from Pro-ACTH/Endorphin
by Mouse Pituitary Tumor Cells
RICHARD E . MAINS and BETTY A. EIPPER
Department of Physiology, University of Colorado Health Sciences Center, Denver, Colorado 80262
ABSTRACT The secretion of peptide products derived from pro-ACTH/endorphin was exam-
ined with several radioimmunoassays and with polyacrylamide gel analyses of immunoprecip-
itates of radioactively labeled peptides . In studies using a mouse pituitary tumor cell line the
accumulation of each of the four molecular forms of adrenocorticotropic hormone (ACTH) in
tissue culture medium was shown to be a linear function of time . No evidence for self-
inhibition of secretion by accumulated, secreted peptides (i.e ., ultra-short feedback) was found .
Furthermore, synthetic human ACTH and synthetic camel /3-endorphin did not alter secretion
of peptides when added to the culture medium at levels up to 10,000 times physiological .
Stimulation of the releaseof ACTH-, endorphin-, lipotropin-, and 16k fragment immunoreactive
material by norepinephrine was fully blocked by cobalt ; by this criterion, stimulated release
was calcium dependent. All the smaller molecules derived from the pro-ACTH/endorphin
common precursor were secreted in equimolar amounts under all circumstances tested, within
the precision of these studies (±11%) . Norepinephrine and cobalt did not significantly alter the
secretion of pro-ACTH/endorphin and ACTH biosynthetic intermediate . The stimulation of
secretion by norephinephrine and inhibition of secretion by cobalt was restricted to the lower
molecular weight products derived from pro-ACTH/endorphin : glycosylated and nonglycosy-
lated ACTH(1-39) ; a-lipotropin,,-endorphin, and y-lipotropin ; and 16k fragment .
The AtT-20/D-16v mouse pituitary tumor cell line, which was
derived from anterior pituitary tissue, provided the first system
in which the common precursor to adrenocorticotropic hor-
mone (ACTH)' and /3-lipotropin (#LPH)/,B-endorphin was
demonstrated (38) . There is now considerable support for the
existence ofa similarcommon precursor to ACTH-related and
endorphin-related peptides (pro-ACTH/endorphin) in many
species and in several different tissues (reviewed in references
5, 16, and 22) . The ACTH/endorphin biosynthetic pathway
that operates in AtT20/D-16v cells is summarized in Fig . 1 .
'Abbreviations usedin thispaper: ACTH, adrenocorticotropic hormone
or corticotropin; 8LPH, /3-lipotropin; yLPH, y-lipotropin or roughly
the NH 2-terminal two-thirds of/8LPH; aMSH ; a-melanotropin or N-
acetyl-ACTH(1-13)NH2 ; CLIP, corticotropin-like intermediate lobe
peptide or ACTH(18-39) ; 16k fragment, theNH2-terminalnon-ACTH,
non-/3LPH region of pro-ACTH/endorphin, containing a melanotro-
pin-like region called yMSH; 31k, 16k, etc., molecules with apparent
molecular weights of 31,000, 16,000, etc., when determined by SDS
polyacrylamide gel electrophoresis using a borate/acetate buffer sys-
tem .
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Under a variety of circumstances, coordinate secretion of
immunoreactive ACTH-related and,8LPH-related peptides has
been observed in humans and in experimental animals ; how-
ever, theamounts ofACTH- and,8LPH-related material found
in plasma have not always been equimolar (1, 3, 20, 23, 24, 31,
61) . Similarly, studies with pituitary tissue in vitro have usually
demonstrated coordinate, although not always equimolar, se-
cretion of ACTH- and #LPH-related material (2, 13, 15, 32,
42, 47, 51, 52, 65). Given the common biosynthetic precursor
to ACTH and LPH, nonequimolar secretion of ACTH- and
LPH-related material would require selective release of por-
tions of the common precursor molecule (recall Fig . 1) . Al-
though many investigators report that ACTH- and LPH-re-
lated material can invariably be located in the same cells by
immunohistochemical staining, there are reports that some cells
in the pituitaryand brain containonlyACTH- or LPH-related
molecules . Whether these observations reflect independent syn-
thesis of ACTH- and 8LPH-related material, selective intra-
cellular degradation of portions of a common precursor mole-
cule, or an artifact of immunostaining is not yet clear (4, 27,
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FIGURE 1
￿
Structure and biosynthetic processing of pro-ACTH/en-
dorphin in mouse pituitary tumor cells . The structure and biosyn-
thetic processing of mouse pituitary tumor cell pro-ACTH/endor-
phin are summarized in reference 16; structures below the dashed
line are shown for comparative purpose.
39, 41, 44, 48, 49, 68, 69) .
Another important question concerns the suggestion that a
number of peptide hormones directly inhibit their own secre-
tion (called an "ultra-short feedback loop") ; data on the exist-
ence of an ultra-short feedback loop for ACTH release are
conflicting (17, 22, 26, 28, 47, 53) .
Control of secretion of immunoreactive ACTH from AtT-
20/D-16v cells hasbeen shown to be responsive to stimulation
by hypothalamic factors, arginine-vasopressin, norepinephrine
or cyclic nucleotide analogues, and to feedback inhibition by
glucocorticoids but not sex steroids or mineralocorticoids (2,
22,53-55,64,67) . Thus,thetumor cells provide amodel system
for studying hormone release from corticotropes ofthe anterior
pituitary . The AtT-20/D-16v cells were used to address the
question of whether coordinate, equimolar secretion of the
various products derived from pro-ACTH/endorphin occurs
during both basalandstimulated secretion, or whether selective
secretion of certain regions of the common precursor could be
observed. In addition, themolecular formsof the pro-ACTH/
endorphin-derived molecules secreted under basal and stimu-
lated conditions were compared . The possibility that ACTH or
endorphin inhibits its own release from AtT-20/D-16v cells
was also investigated .
Monolayer cultures of AtT-20/D-16v mouse pituitary tumor cells were main-
tained in Dulbecco-Vogt modified Eagle's medium with 2.5% horse serum,
glucose, glutamine, and antibiotics (10). Release of immunoreactive molecules
from identical dishes of tumor cells was determined after incubation in fresh
complete culture medium containing test agents that might alter secretion;
medium was removed from the cells, treated with protease inhibitors (phenyl-
methylsulfonyl fluoride and iodoacetamide; 0.3 mg/ml each) (34), and secreted
hormones were measured by the appropriate radioimmunoassays and bioassays,
as described previously (10, 13, 14, 18, 34,35). No degradationor interconversion
of hormonesoccurs aftersecretion under these incubation conditions (35 ; see also
Results).
The release of radiolabeled proteins was studied by incubation of identical
microwellsoftumor cells (usually5 x l0' cells/well) in 100ILl ofcomplete culture
medium containing [3H]phenylalanine (150 pM; 55 Ci/mmol ; New England
Nuclear, Boston, Mass.), [3H]tyrosine (150 pM; 53 or 13 .4 Ci/mmol [see appro-
priate legends] New England Nuclear), or [3H]histidine (150 PM; 12 Ci/mmol;
New England Nuclear) (34, 35). After various periods of labeling, radioactive
medium was removed and treated with protease inhibitors as above . In some
experiments, several microwells ofcells were incubated for 7-15 h in radioactive
medium ; one microwell o£ cells was extracted with 5 N acetic acid plus protease
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inhibitors (34), and the remaining microwells were rinsed with complete nonra-
dioactivemediumandthen incubated for 60 min infresh, nonradioactive medium
containing test substances. This procedure diluted the radiolabel at least 1,000-
fold and halted further measurable incorporation of the radiolabelinto protein
(34, 35). Medium containing secreted protein was removed and combined with
protease inhibitors ; cells were extracted with acid plus protease inhibitors . In all
experiments, the total amount of radioactive pro-ACTH/endorphin-related ma-
terial present in the cell extracts at the end of the prelabeling period was
quantitatively accounted for by the sum of the labeled hormone in the cell
extracts plus theculture medium after the I-h chase incubation in nonradioactive
medium (t15%) (35) .
Radiolabeled hormones were isolated from cell extracts and culture media by
sequential double antibody immunoprecipitation by useofaffinity-purified rabbit
antibodies and goat anti-rabbit immunoglobulin (34-36). The immunoprecipi-
tation methods have previously been shown to be both specific and quantitative.
Antibody specificity was determined by blocking immunoprecipitations with an
excess of the appropriate synthetic or purified mouse tumor peptide . Immuno-
precipitates were analyzed by SDS polyacrylamide gel electrophoresis (11.25%
acrylamide,0.59% NN'-methylenebisacrylamide, borate/acetate buffer,pH 8.5)
or by gel filtration in 6 M guanidine HCI, 0.2 mg/ml bovine serum albumin
(Sephadex G-50 superfine) (12) .
The number of tyrosine residues in the various molecules biosynthetically
derived from mouse tumor pro-ACTH/endorphin was determined from the
amino acid compositions of the purified proteins andfrom analyses of radiola-
beled tryptic and chymotryptic peptides (11, 12, 14, 29) . Thenumber oftyrosine
residues in each of the major mouse tumor cell pro-ACTH/endorphin-related
molecules is: ,B-endorphin, 1 ; yLPH, l ; /3LPH, 2 ; ACTH(1-39), 2(one in a-
melanotropin [aMSH] and the other in corticotropin-like intermediate lobe
peptide [CLIP]) ; 16k fragment, 1 (in the region known as YMSH) ; ACTH
biosynthetic intermediate, 3 ; pro-ACTH/endorphin, 5 .
RESULTS
Linear Accumulation of ACTH in Culture
Medium as a Function of Time
In agreement with the results of Herbert et al. (22) and
Watanabe et al . (67), it was found in five experiments that the
daily accumulation of immunoactive and bioactiveACTH Lug
ACTH(1-39) equivalents/milligram cell protein/day] in several
culture media (F-10, L-15, Dulbecco's modified Eagle's me-
dium) was constant (f20%) for a wide range of cell densities,
both in thepresence andabsence ofhorse serum . Accumulation
of immunoactive ACTH in the medium was linear in time for
up to 24 h in each of 13 experiments ; one such experiment is
shown in Fig . 2 . Similar results were obtained with five differ-
entACTH antisera with specificities that span the structure of
ACTH(1-39) . Accumulation of bioactiveACTH in themedium
was also linear in time, using two different adrenal cell bioassay
systems . The amount of bioactive ACTH was roughly two-
thirds of the amount of immunoactive ACTH in the medium ;
the relatively low steroidogenic potency of pro-ACTH/endor-
phin andACTH biosynthetic intermediate (18) would account
for this result.
For a study of the secretion of each of the four major
molecularforms ofACTH, identical microwells of AtT-20/D-
16v cells were incubated for increasing periods of time in
medium containing a radioactiveamino acid andthe release of
each molecular form of ACTH wasexamined by immunopre-
cipitation and SDS polyacrylamide gel electrophoresis . In five
experiments, the accumulation of each form of radioactive
ACTH was found to be linear in time afteran initial lagperiod
(during which the intracellular hormone pools were labeling);
one such experiment is shown in Fig . 3 . At the end of 30 min
of incubation, the only form of radioactive ACTH in the
medium was pro-ACTH/endorphin . Later in the incubation,
labeledACTH biosynthetic intermediate began appearing in
the medium at a rate that remained constant for the duration
of the study . After a lag of 1-1 .5 h, the two formsofACTH(1-0 I
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FIGURE 2
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Accumulation of immunoactive ACTH in AtT-20/D-16v
culture medium as a function of time . The accumulation of immu-
noactiveACTH in the medium of adense dish of AtT-20/D-16v cells
was measured ; cells (2 .2 mg cellular protein) in a 60-mm culture
dish were fed with 5 ml of Dulbecco's modified Eagle's medium
containing 2.5% horse serum; 3 h later (time zero in the figure) this
medium was removed and 2.60 ml of fresh medium was placed on
the cells . Samples of medium (0.20 ml) were removed at 10 min, 60
min, 4 h, and 22 h . ACTH was measured by radioimmunoassay with
an NHz-terminal ACTH antiserum and with a bioassay using Y-1
mouse adrenal tumor cells (10) ; only the immunoassay data are
shown. The vertical bars represent the standard deviations of the
data from two independent radioimmunoassays of the same sam-
ples (a total of 10-12 determinations per data point) .
39) (with and without the oligosaccharide chain attached in the
COOH-terminal half of the molecule) began appearing in the
medium at a constant rate .
Coordinate, Equimolar Secretion of
Immunoactive Molecules Related to Pro-ACTH/
Endorphin
The secretion of ACTH-related, endorphin-related, LPH-
related, and 16k fragment-related molecules by the mouse
pituitary tumor cells was first studied using radioimmunoas-
says. In 17 experiments, the basal release of immunoactive
ACTH-, endorphin-, and 16k fragment-related molecules was
nearly equimolar (within ±25%) . Because basal release of
ACTH-related molecules was linear in time for many hours
(Figs . 2 and 3), the effects of agents that alter secretory rates
were studied by examining the accumulation of hormones in
the medium after a convenient fixed period of time, generally
Ior2h .
Norepinephrine was previously reported to stimulate release
ofACTH from rat anterior pituitary tissue in vitro (51, 65, 66) ;
we confirmed that secretion of pro-ACTH/endorphin-related
molecules from AtT-20 cells was stimulated in a graded fashion
by norepinephrine in the concentration range of 0.01-1.0 PM .
The stimulation by norepinephrine was a mixed a- and f3-
agonist action : stimulated release was partially blocked by
addition of propranolol (a Q-blocker; 0.05-1 p,M) and partially
mimicked by phenylephrine (an a-agonist; 1-10 IiM) and by
isoproterenol (a fl-agonist ; 1-10 [,M) . In six experiments, secre-
tion of immunoactive ACTH, endorphin, and l6k fragment
remained nearly equimolar in the presence of 1 .5- to 3.0-fold
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FIGURE 3 Accumulation of multiple radiolabeled forms of ACTH
in AtT-20/D-16v cell culture medium . Four identical microwells of
mouse pituitary tumor cells were incubated in complete medium
containing [3H]tyrosine (2,3-side chain labeled ; 13 .4 Ci/mmol ; 150
AM) for the times indicated . Samples of culture medium were
analyzed by immunoprecipitation with the middleACTH antiserum
(Bertha ; reference 34) and SDS polyacrylamide gel electrophoresis.
The amount of label appearing in each form of ACTH at each time
was calculated by summing the radioactivity in each peak of the
SDS polyacrylamide gel profile and these totals are plotted . The
incorporation of radiolabel into 12.5% trichloroacetic acid-precipi-
table cellular material was a linear function of time for the entire
incubation ; at 8 h, the cell extracts contained 7.5 x 106 cpm (25 x
10 6 dpm) acid-precipitable material .
o pro-ACTH/endorphin
" ACTH biosynthetic intermediate
n glycosyloted ACTH (I-39)
* < ACTH (1-39)
D
stimulations ofhormone release above the basal rate; one such
experiment is reported in Table I. Hormone release was stim-
ulated from 2.2- to 2.9-fold, depending on the immunoassay
used .
In studying the actions of test substances on hormone release
by pituitary cells, it is crucial to monitor the general state of
health of the cells. The ability of the cells to incorporate a
radioactive amino acid into material precipitable with 12.5%
trichloroacetic acid was used as a measure of cellular health.
By use of this criterion, satisfactory conditions for studying
directly the role of extracellular calcium in hormone secretion
could not be established ; only when cell health was compro-
mised (by addition of EDTA or EGTA, 1-2.5 mM) could
hormone secretion be inhibited . An alternate approach for
investigating the role of calcium in secretion involved the use
ofcalcium antagonists; cobalt is known to be a potent compet-
itive antagonist of extracellular calcium actions inmany secre-
tory systems (9, 30, 59, 62) . Addition ofCOC12 at concentrations
up to 1 mM did not inhibit the ability of the tumor cells to
incorporate radioactive amino acids into acid-precipitable ma-
terial (see legend to Table I). As shown in Table 1, COC12 had
no significant inhibitory effect on the basal secretion of im-
munoactive ACTH, endorphin, 16k fragment, or yLPH . The
stimulation of release caused by 10 ttM norepinephrine was
abolished in the presence of 1 mM CoCl2 . By the criterion of
cobalt inhibition, basal secretion from AtT-20/D-16v cells is
not calcium-dependent, whereas the norepinephrine-stimu-
lated increment in secretion is calcium-dependent .
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23TABLE I
Stimulation andInhibition of Releaseof Pro-ACTH/
Endorphin-related Products
Identical 35-mm dishes of AtT-20/D-16v cells were incubated for 60 min in
1 .00 ml of fresh, complete culture medium containing [3H]leucine (5 JLCi/ml,
final sp act 6.26mCi/mmol) ; medium contained no additives ("none"), 1 mM
COC12 , and/or 10 pM norepinephrine bitartrate (made fresh within 2 min of
the start of the 60-min incubation) . Media were harvested with protease
inhibitors (34) . Cell health was monitored by determining the ability of the
cells to synthesize new, radioactive proteins during the test treatments . The
cells were extracted with 0.8 ml of 100 mM NaOH and the extracts were
precipitated with 0.8 ml of 25% trichloroacetic acid ; the four sets of duplicate
cell extracts were identical, and contained 10,800 t 1,100cpm (mean t SD)
of acid-precipitable material . Release is reported as a fraction of basal release,
which was set at 1 .0 . Data for release are highly dependent on the antibodies
and immunoassay standards used . For these experiments, the basal concen-
trations were (in nM): ACTH, 5.6; endorphin, 5.4; 16k fragment, 7.3 ; LPH, 6.0.
All immunoassays were performed at least in duplicate, with at least 10 points
averaged for each number reported; the standard deviation of each average
value in the table was <<-12% .
Absence of Self-inhibition of Release (-ultra-
short Loop Feedback")
Based on accumulation of immunoactive, bioactive, or ra-
diolabeled ACTH in the culture medium (Figs . 2 and 3), the
AtT-20/D-16v cells used in this work do not seem to exhibit
"ultra-short loop feedback." Other reports ofAtT-20 secretion
are in disagreement on this point (22, 53, 60, 67) . Because basal
and stimulated secretion of all the peptide products derived
from pro-ACTH/endorphin is roughly equimolar (Table 1), a
further test of whether ACTH or Q-endorphin can inhibit
secretion by AtT-20 cells is possible . Synthetic ACTH or fl-
endorphin was added to culture media at the start of the 6-h
incubation .
Table II shows that the peptides added to the media were
stable in the medium in the absence ofcells, and that only the
homologous assay detected its peptide. Again, basal or control
secretion of immunoactive ACTH, endorphin, 16k fragment,
and LPH was equimolar . Synthetic ACTH was not detectably
degraded in the presence of the AtT-20/D-16v cells, and did
not alter the secretion of endorphin, 16k fragment, and LPH.
115I-labeledACTH was also stable (>98.6% remained intact, as
determined by gel filtration) after 13 h in the presence of the
tumor cells (not shown) . Likewise, syntheticendorphin wasnot
measurably degraded by the cellsand did not alter secretionof
ACTH, 16k fragment, and LPH. The concentrations of syn-
thetic ACTH and endorphin added to the media were about
10,000-fold greater than physiological levels (1, 3, 23, 24, 31,
61) .
Coordinate Secretion of Radiolabeled Molecules
Related to Pro-ACTH/ Endorphin
To investigate which molecular forms ofACTH, LPH, en-
dorphin, and 16k fragment-related material were secreted un-
der basal and stimulated conditions, AtT-20/D-16v cells were
incubated in medium containing [3H]tyrosine for 7 h (a period
of time sufficient to label >90% of the intracellular hormone
24
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TABLE II
Test of Ultra-shortFeedback
Immunoactive Peptide
,8-endor-
￿
16k frag-
ACTH phin ment yLPH
nM
Medium - Cells
Control
+ hACTH
+ f.endo
Identical dishes of AtT-20/D-16v cells were incubated in fresh medium with
2.5% horseserum for6 h, and medium was harvested with protease inhibitors.
To some dishes, synthetichumanACTH(1-39) (nominally 195 nM) or camel
-endorphin(1-31) (nominally259nM) were added . Control samples of media
with added peptides (but without cells) were also incubated for 6 h and
harvested . Three or four dishes were used with each of the three media tested ;
all radioimmunoassays yielded >-5 data points per dish . The standard devia-
tions of all values shown were 510% .
stores [15]) . Secretion of radiolabeled hormones was examined
during an additional hour of incubation in fresh, nonradioac-
tive medium containing agents capableofaltering the secretory
rate. It hasbeenshown that, under these incubation conditions,
no significant intra- or extracellular degradation of pro-
ACTH/endorphin-related material occurred (15, 35, 36) . The
present experiments confirmed theprevious results.
The release of [3H]tyrosine-labeled molecules immunopre-
cipitable with a middle ACTH antibody during basal, norepi-
nephrine (1 p,M), and cobalt (1 mM) treatments is shown in
Fig. 4A . As in Fig. 3, all four major size classes of ACTH-
related material were released into the medium under basal
conditions : pro-ACTH/endorphin [31k], ACTH biosynthetic
intermediate [21k], glycosylated ACTH(1-39) [13.5k] and
ACTH(1-39) or <ACTH(1-39) [<_4.5k] . Norepinephrine stim-
ulated the secretion ofeach ofthe two smallerpeaks ofACTH
about fivefold, while the release of pro-ACTH/endorphin and
ACTH biosynthetic intermediate was not significantly altered .
Cobalt had a negligible effect on basal secretion of any of the
four forms ofACTH .
In addition to the ACTH-related material recognized by the
middle ACTH antibody, a small amount of N1-12-terminal
ACTH-immunoprecipitable material (approximately the size
of aMSH) was also secreted (Fig. 4B); this material was
obtained from the labeled molecules not immunoprecipitated
by themiddle ACTH antiserum . On a molar basis, the secreted
NH2-terminal ACTH-related material amounted to only a
tenth to a twentieth of the amount of secreted ACTH(1-39)
plus glycosylated ACTH(1-39) . The middle ACTH antibody
will immunoprecipitate molecules similar to CLIP [ACTH(18-
39) ; reference 37], so the small amount of CLIP-like material
expected to correspond to the NH2-terminal ACTH-reactive
material in Fig. 4B would be present in the 13.5k and 4.5k
peaks in Fig.4A . Norepinephrine stimulated secretionofNH 2-
terminal ACTH-related material eightfold. Analyses of tryptic
peptides showed that none of NH2-terminal ACTH-reactive
material in Fig . 4B had an acetylated aminoterminus and thus
is not genuine aMSH .
Theaccumulation oflabeled endorphin-related molecules in
the medium was examined afterACTH-related molecules had
Additions to medium ACTH
Endor-
phin
Immunoactivity
LPH
16k frag-
ment
None 1 .0 1.0 1.0 1 .0 Medium + Cells
COC12 0.8 0.9 0.8 0.8 Control
Norepinephrine 2.2 2.4 2.2 2.9 + hACTH
Norepinephrine + COC12 0.7 0.8 0.9 1.0 +f.endo
21 27 20 24
214 26 23 26
24 299 22 28
<0 .2 <0 .2 <0.02 <0.02
188 <0 .2 <0.02 <0.02
<0.2 271 <0.02 <0.0216
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FIGURE 4
￿
Release of radiolabeled ACTH-related molecules . Three
identical microwells of AtT-20/D-16v cells were incubated for 7 h in
basal, complete culture medium containing [3H]tyrosine (150 faM ;
3,5-ring labeled ; 53 Ci/mmol) and then rinsed and chased in 500 AI
complete nonradioactive medium for 1 h containing no additives
("basal"), 1 pM norepinephrine bitartrate ("NE"), or 1 MM COC1 2
("cobalt") . Samples of medium (150 pl) were immunoprecipitated
with middle ACTH antiserum (A) and analyzed on SDS polyacryl-
amide gels . The supernate from the middle ACTH immunoprecipi-
tate was immunoprecipitated with theNH2-terminal ACTH antibody
(which reacts with aMSH as well as ACTH) and analyzed by gel
filtration in 6 M guanidine HCI (8) . In A, the heavy arrow marks the
position of the internal dansylated cytochrome c marker ; in B, the
arrow marks the position of the internal glucagon marker .
been removed from the medium by immunoprecipitation . Ad-
dition ofnorepinephrine stimulated the secretion ofPLPH(12k)
and /3-endorphin (3.5k) three- and sixfold, respectively, over
basal levels (Fig . 5A) . COC1 2 (1 mM) did not significantly alter
basal secretion (not shown), in agreement with the lack of
effect of cobalt on basal ACTH secretion (Fig . 4A) .
After ACTH- and endorphin-related molecules were re-
moved from the medium, antiserum to mouse tumor cell yLPH
was used to examine secretion of yLPH-related material (8k ;
Fig . 5 B) . Norepinephrine stimulated secretion of yLPH-reac-
tive radioactive molecules sixfold; cobalt again had no signifi-
cant effect on basal secretion . A small amount of 2.5k yLPH-
related material appeared in the norepinephrine-stimulated
sample but not in the basal or cobalt samples .
Finally, the same samples ofmedium were used to investigate
release of 16k fragment-related material (Fig . 6) . After removal
of ACTH-related material (as in Fig . 4), the 16k fragment
antibody immunoprecipitated a heterogeneous collection of
16k fragment-related material with apparent molecular weights
of 18k to 13k . Norepinephrine stimulated the secretion of the
heterogeneous 16k fragment-related material fivefold ; in ad-
dition, a peak of lower molecular weight 16k fragment-related
material was detected (4k) . As before, cobalt did not signifi-
A . Endorphin after ACTH
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Basal
8
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FIGURE 5
￿
Release of radiolabeled LPH-related molecules . Samples
of medium analyzed with ACTH antisera in Fig . 4 were next immu-
noprecipitated with antisera to endorphin (A) and then with antisera
to mouse tumor cell yLPH (8) and analyzed on SDS polyacrylamide
gels . The heavy arrow marks the position of the internal dansylated
cytochrome c marker on each gel .
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￿
Release of radiolabeled 16k fragment-related molecules .
Samples identical to those analyzed in Fig . 4 were immunoprecipi-
tated with ACTH antisera and next immunoprecipitated with anti-
sera to mouse tumor cell 16k fragment; the 16k fragment immuno-
precipitates were analyzed on SDS polyacrylamide gels . The heavy
arrow marks the position of the internal dansylated cytochrome c
marker on each gel .
cantly alter basal secretion of 16k fragment.
Results completely in agreement with the data in Figs . 4-6
were obtained in two other experiments in which [3H]phenyl-
alanine was used to label the molecules before secretion, and
in one experiment in which [ 3H]histidine was used .
Coordinate Secretion is Equimolar Secretion
The radioactivity in each peak in Figs. 4-6 was summed and
normalized in Table 111; molecules have been grouped accord-
ing to major branch points in the biosynthetic pathway (Fig .
1) . The number of tyrosine residues in each molecule was used
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25TABLE III
Equimolar, Coordinate Secretion of Smaller Peptide Products
Derived from Pro-ACTK/ Endorphin
cpm (Normal-
ized)/molecule
Data from Figs . 4-6 are summarized in tabular form . Normalized cpm/
molecule equals cpm/molecule divided by the number of tyrosine residues
in that molecule . Data are for 150 pl of medium ; total cpm released per
microwell (500 Al) can be obtained by multiplying data by 3.33 and by the
number of tyrosine residues . Repetition of all the original immunoprecipi-
tations, followed by SDS gel analyses, yielded values within 10% of those
shown in this table; these data are for the particular set of immunoprecipi-
tations shown in Figs . 4-6 . The total secretion of ACTH-related molecules,
including pro-ACTH/endorphin and ACTH biosynthetic intermediate, was
1,392 normalized cpm; for #LPH, including pro-ACTH/endorphin, 1,173
normalized cpm; for 16k fragment, including pro-ACTH/endorphin and
biosynthetic intermediate, 1,321 normalized cpm.
* Presumably includes a small amount of material similar to CLIP to corre-
spond to the NH z-terminal material, in addition to intact ACTH(1-39) .
$ Calculated by adding total ACTH-related radioactivity (middle + NHZ-
terminal) and then dividing by two tyrosine residues .
§ Calculated by adding #LPH +f3-endorphin + yLPH radioactivity and then
dividing by two tyrosine residues .
to normalize the amount of radioactivity in each protein . After
dividing the amount of radioactivity in each peak by the
appropriate number of tyrosine residues, the normalized ra-
dioactivities can be compared directly on a molar basis . This
comparison does not depend on equilibration of the intracel-
lular and extracellular radioactive amino acid pools . Rather,
the calculation depends only on the validity of the pathway in
Fig . 1 and on the correctness of the assignments of tyrosine
residues .
Two important points should be noted about the data for
pro-ACTH/endorphin and ACTH biosynthetic intermediate.
First, the two biggest forms of ACTH comprise -25% of the
moles ofACTH-related material secreted by the tumor cells in
the basal state, in agreement with our previous tumor cell data
(10, 34, 38) . Second, there was no significant change (±13%) in
the secretion ofpro-ACTH/endorphin and ACTH biosynthetic
intermediate in the presence of norepinephrine. In the stimu-
lated state, then, the two largest forms ofACTH accounted for
only 7% of the total moles ofACTH secreted .
In the basal state, the accumulation of 16k fragment-,
LPH-, and ACTH-related material in the medium was equal
(981, 973, 1,052 normalized cpm/molecule, respectively) .
Within the LPH class, the basal secretion of f3-endorphin (437
normalized cpm/molecule) matched the basal secretion of
yLPH (405 normalized cpm/molecule) . Each ofthese results is
predicted from Fig . 1 if no degradation of the major pieces of
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pro-ACTH/endorphin occurs either before or after secretion .
After stimulation with norepinephrine, the equimolar secre-
tion of products derived from pro-ACTH/endorphin was
maintained . For example, the secretion of lbk fragment-related
material (4,779 normalized cpm/molecule) was closely
matched by the secretion of ACTH(1-39)-related material
(4,974 normalized cpm/molecule) and only exceeded the secre-
tion ofLPH-related material (4,266 normalized cpm/molecule)
by 11% . Again, the stimulated secretion of 8-endorphin
matched the level foryLPH (within 8%) .
As a consequence of equimolar, coordinate release of the
peptide products derived from pro-ACTH/endorphin, in both
basal and stimulated states, the increments in secretion caused
by norepinephrine were also equimolar: ACTH(1-39)-related,
,SLPH-related, and 16k fragment-related increases were the
same within±9%; fl-endorphin and yLPH increases were equal
within t5% .
In both [3H)phenylalanine experiments discussed above, the
basal and incremental secretions of smaller peptide products
derived from pro-ACTH/endorphin were also equimolar
within ±11% . In the [3H)histidine experiment, only endorphin-
related molecules were examined; norepinephrine stimulated
secretion of,l3LPH and,8-endorphin but had no effect on pro-
ACTH/endorphin secretion. Cobalt fully blocked the increased
secretion of,8LPH and,(3-endorphin caused by norepinephrine .
DISCUSSION
In this work, the AtT-20/D-16v mouse pituitary tumor cells
were used to demonstrate coordinate, equimolar release of all
the smaller peptides derived biosynthetically frompro-ACTH/
endorphin . Coordinate equimolar release was observed during
both basal and norepinephrine-stimulated secretion, within the
limits of the methods employed (t11%). The use of quantitative
immunoprecipitation of radiolabeled molecules allowed a di-
rect molar comparison of secretion of different regions of pro-
ACTH/endorphin, and avoided the difficulties inherent when
exclusively using radioimmunoassays to estimate several dif-
ferent molecular forms of a hormone. It is important to note
that most of the 16k fragment secreted was intact or nearly
intact 16k fragment, and not cleaved to products such as the
potential 12 amino acid product yMSH (43) (Fig . 1) . Primary
rat anterior pituitary cultures were also found to secrete almost
exclusively intact l6k fragment under basal conditions (15) .
Coordinate, equimolar secretion would be expected from the
biosynthetic pathway in Fig. 1, if little or no degradation
occurred before or after secretion . Previous work (35) showed
that there is coordinate, equimolar synthesis and secretion of
ACTH- and endorphin-related molecules in AtT-20/D-16v
cells under basal conditions; the present work extends the
previous results to include all of the smaller peptides derived
from pro-ACTH/endorphin, and to study both the basal and
stimulated states . The possibility of intracellular degradation
ofhormone during acute or chronic inhibition ofsecretion was
not investigated in this work; such degradation has been seen
for both parathyroid hormone (33, 40) and insulin (21) .
Equimolar, coordinate secretion of all the peptides derived
from pro-ACTH/endorphin would also be expected using
normal anterior pituitary tissue ; the biosynthetic pathway in
the rat anterior pituitary is the same as that in the AtT-20 cells
(37) . In our studies, basal secretion from isolated rat anterior
pituitary cells has always been coordinate and equimolar (15) .
Coordinate but clearly not equimolar secretion has been re-
Form of molecule
No . of ty-
rosine
residues Basal
NE-in-
crement
Ratio, in-
crement :
basal
Pro-ACTH/endorphin 5 200 25 0.1
ACTH biosynthetic inter- 3 140 -9 -0.1
mediate
Glycosylated ACTH(1- 2 666 2,218 3.3
39)
ACTH(1-39)* 2 359 1,507 4.2
NHz-terminal ACTH-re- 1 55 393 7.1
active material
Total ACTH(1-39)-re- 2 1,052 3,922 3.7
fated$
#1-PH 2 552 1,247 2.3
,8-endorphin 1 437 2,139 4.9
yLPH 1 405 1,953 4.8
Total #LPH-related§ 2 973 3,293 3.4
Total 16k fragment-re- 1 981 3,798 3.9
latedported in work on primary anterior pituitary cultures (2, 32,
42, 47, 52). Because the recovery of exogenous peptides in the
sampling medium and the stability of endogenous secreted
moleculeswere not reported in most other studies, it is difficult
to compare previous results to the data in this paper .
One of the clearest demonstrations ofinhibition of secretion
by the products of prior secretion involves collagen; fibroblasts
are inhibited from further secretion of collagen by the globular
(but not the helical) region of previously secreted or exoge-
nously added collagen molecules (70). Another good example
is somatostatin secretion by pancreatic islets (25) . In many
other studies reporting inhibition of secretion by previously
secreted peptides, tissue viability and stability ofpeptides after
secretion were incompletely documented . The data on ACTH
secretion from AtT-20 cells and from primary rat anterior
pituitary tissue are conflicting (17, 22, 26, 28, 47, 53) . Two
previous reports ofsecretionby AtT-20 cells found secretion to
be continuous formany hours (22, 67), as in this study . Because
exogenous and endogenous ACTH (53), endorphins (55, 60),
and melanotropins (57) are sometimes degraded in cultures
with half-lives of the order of 10 min to 2 h, a lack of stability
after secretion can be confused with a decreased secretory rate .
Under the incubation conditions used in these and previous
studies (Figs. 2 and 3; Table II ; reference 35), endogenous and
exogenous hormonal peptides were stable after secretion into
the culture medium . It has been suggested that autoregulation
of secretion only occurs at high cell densities and high hormone
concentrations (53) ; in Fig . 2 and Table II, no evidence for
autoregulation of secretion was seen at hormone levels four
orders of magnitude above the highest levels found in blood
(1, 3, 23, 24, 31, 61) . Plateau levels of endorphin and ACTH
secretion found in some other studies of AtT-20 cells (53, 60)
were <1% of the levels achieved in this work (Fig. 2) and in
previous studies by other groups (22, 67) . The hormone levels
shown in Fig . 2 and Table I are not overestimates, as the
amounts have been determined with five different ACTH and
two different endorphin radioimmunoassays, two different
ACTH bioassays, an opiate bioassay, and by quantitative
aminoacid analyses after purification of the secreted hormonal
peptides (10, 12, 14, 18, 29, 34) .
The AtT-20/D-16v mouse pituitary tumor cells have a very
high basal rate of secretion; ~15% of cellular hormone content
is secreted per hour (10, 22, 34; Fig . 2) . By comparison, basal
secretion from primary rat anterior pituitary cells is only -0.4%
of cellular hormone content/hour (15) . Even with such a high
basal secretion rate, the mouse tumor cells were stimulated by
norepinephrine to release additional hormone (Tables I and
111, Figs . 4-6). When considering the actions of pro-ACTH/
endorphin-related molecules after secretion, the important re-
sult is that the increased release caused by norepinephrine is
almost exclusively in the smaller, more bioactive molecules-,
ACTH(1-39) and glycosylated ACTH(1-39) are much more
active than the larger molecules at stimulating steroidogenesis
in the adrenals (18), and only ,8-endorphin has substantial
opiate activity (14). In similar but less fully analyzed experi-
ments, stimulated primary anterior pituitary cells also released
mainly smaller peptides (13, 65) . In many other tissues, the
molecular composition of basal secretion is not the same as
stimulated secretion (7, 8, 33, 40, 50, 56, 63) .
The ionic basis of secretion ofpeptides from AtT-20 cells is
not yet clear . Depolarization of anterior pituitary cells by
exposure to elevated potassium causes release of ACTH (30,
51) ; ionized external calcium is required for potassium- and
hypothalamic extract-stimulated secretion of ACTH (19, 30,
51). The AtT-20 cells have been reported to increase their
secretion ratewhen exposed to elevated potassium (54, 60), but
only for periods of a few minutes; when AtT-20 cells are
exposed to elevated potassium for 1 h (a time commonly used
in studies of secretion ofACTH by normal anterior pituitary),
no detectable increase over basal secretion is found (54, 60 ; R.
E. Mains and B. A . Eipper, unpublished observations) . Simi-
larly, GH 3 rat pituitary tumor cells exhibit increased growth
hormone secretion in elevated potassiumonly forafewminutes
(45) . Ionized extracellular calcium is required for stimulated
but not basal secretion from both normal and tumor cells
(Table I ; Figs . 4-6; 19, 30, 54, 60) . Basal secretion from many
other peptide-secreting tissues is also independent of ionized
extracellular calcium (6, 58, 59, 63) . Interestingly, AtT-20/D-
lbv cells are capable of exhibiting regenerative changes in
membrane potential which have pharmacological properties
similar to calcium action potentials .'
These studies extend work on several peptide-secreting tis-
sues which shows that the molecular compositions and ionic
dependence of basal and stimulated secretions are often differ-
ent . Frequently, the molecular composition of only the stimu-
lated component of secretion correlates well with analyses of
the molecular composition of the soluble contents of secretory
granules, whichare generallypresumed to release theircontents
by exocytosis (46) . The cellular basis of basal secretion is
unclear; it could reflect heterogeneityamongthe cells oramong
secretory granules inside the cells . Alternatively, basal secretion
might originate in subcellular organelles other than conven-
tional secretory granules .
We thank Diane Honnecke for her patience andsuperb assistance, and
George Tarver for the illustrations . Carol Lipper and Chuck Estin
performed several initial experiments that were very useful in choosing
the experimental conditions used in this work .
This work was supported by National Institutes of Health grants
AM-19859 and AM-18929.
Received for publication 2 September 1980, and in revised form 1
December 1980.
REFERENCES
l . Akil, H., S. J. Watson, l . D . Barchas, and C. H. Li. 1979. fl-endorphin immunoactivity in
rat and human blood : immunoassay, comparative levelsandphysiological alterations. Life
Sci. 24:1659-1666 .
2. Allen, R . G ., E . Herbert, M . Hinman, H . Shibuya, and C. B . Pert. 1978. Coordinate
control ofACTH, PLPH, and f3-endorphin release in mouse pituitary cell cultures . Proc.
Natl. Acad Set . U. S. A . 75:4972-4976 .
3 . Bloomfield, G. A ., A . P. Scott, P. J . Lowry, J. J . H . Gilkes, and L . H . Rees . 1978 . A
reappraisal ofhuman,8MSH . Nature (Loud.) . 252:492-493 .
4 . Bugnon C., B . Block, D . Lenys, and D. Fellmann. 1979. Infundibular neurons of the
human hypothalamus simultaneously reactive with antisera against endorphins, ACTH,
MSH, and PLPH . Cell Tissue Res. 199 :177-196 .
5 . Chretien, M ., S. Benjannet, F. Gossard, C . Gianoulakis, P. Crine, M. Lis, and N . G .
Seidah. 1979. From fl-lipotropin to fJ-endorphin and proopiomelanocortin . Can. J. Bio-
chem. 57:1111-1121 .
6 . Conn, P. M ., D. C . Rogers. 1979 . Restorationofresponsiveness to gonadotropin releasing
hormone in calcium-depleted rat pituitary cells . Life Sci 24:2461-2465 .
7 . Dagom, J . C . 1978 . Nonparallel enzyme secretion from rat pancreas : in vivo studies. J.
Physiol . (Lond.) 280:435-448 .
8 . Dagom, J . C ., and A. Estival. 1979 . Nonparallel enzyme secretion from rat pancreas: in
vitro studies . J . Physiol . (Lond .). 290:51-58 .
9 . Douglas, W . W . 1973. How do neurons secrete peptides? Prog. Brain Res. 39:21-39.
10 . Eipper, B. A ., and R . E . Mains . 1975 . High molecular weight forts ofACTH in themouse
pituitary and in a mouse pituitary tumor cell line . Biochemistry. 14:3836-3844.
11 . Eipper, B . A ., and R . E. Mains . 1977 . Peptide analysis ofa glycoprotein form ofACTH.
J . Biol Chem, 252:8821-8832 .
12 . Eipper, B . A ., and R . E . Mains. 1978. Analysis ofthe common precursor to corticotropin
and endorphin . J. Biol. Chem. 253:5732-5744.
13 . Eipper, B. A ., and R. E. Mains . 1978. Existence of a common precursor to ACTH and
2 Martin, A . R. 1980 . Some electrophysiological properties of pituitary
tumor cells . Society for Neuroscience Abstracts . 97 .
MAINS AND EIPPER
￿
Secretion of ACTH, Endorphin, and 16k Fragment
￿
27endorphin in the anterior and intermediate lobes of the rat pituitary. J. Supramol. Struct.
8:247-262.
14 . Eipper, B. A., and R. E . Mains . 1979. Characterization ofmousetumor cell f-lipotropin .
J. Biol. Chem. 254:10190-10199 .
15 . Eipper, B. A ., and R. E . Mains . 1980 . Basal secretionofpeptides derived from theACTH/
endorphin precursor by rat pituitary cells in culture . In Brain and pituitary Peptides.W .
Wuttke, A . Weindl, K. H. Voigt, and R . R . Dries, editors . S. Karger, Basel, Switzerland .
12-20 .
16 . Eipper, B. A ., and R. E . Mains . 1980. Structureandbiosynthesis ofpro-ACTH/endorphin
and related peptides . Endocrine Rev. 1 :1-27 .
17 . Felon, H . L., K . H. Voigi, R. Lang, and E. F . Pfeiffer. 1974. No "ultra-short feedback
mechanism" for ACTH. Neuroendocrinology. 16:364-368.
18 . Gasson, J . C. 1979. Steroidogenic activityofhigh molecular weight forms ofcorticotropin.
Biochemistry 18:4215-4224.
19 . Gillies, G., and P . J . Lowry . 1978. Perfused rat isolated anterior pituitary cell column as
a bioassay for factors controlling release of ACTH: validation ofa technique . Endocrinol-
ogy. 103:521-527.
20. Guillemin, R., T. Vargo, J . Rossier, S. Minick, N. Ling, C . Rivier,W. Vale, and F . Bloom .
1977.,O-endorphin and ACTH are secreted concomitantly by the pituitary gland . Science
(Wash. D . C .). 197:1367-1369 .
21 . Halban, P. A ., and C . B . WolBreim. 1980. Intracellular degradation of insulin stores by rat
pancreatic islets in vitro . J. Biol . Chem 255 :6003-6006 .
22. Herbert, E .,M. Phillips, M . Hinman, J. L. Roberts, M. Budarf, and T. L. Paquette . 1980.
Processing of the common precursor to ACTH and endorphin in mouse pituitary tumor
cells and monolayer cultures from mouse anterior pituitary. In Synthesis and Release of
Adenohypophyseal Hormones. M . JutiszandK.W. McKems, editors . Plenum Press,New
York. 237-261 .
23 . Hollt, V ., O . A. Muller, R. Rahlbusch . 1979. fl-endorphin in human plasma : basal and
pathologically elevated levels . Life Sci . 25:37-44.
24. Imura H., Y. Nakai, K . Nakao, and H. Jingami . 1979 . Concomitant increase ofplasma
J!-endorphin and ACTH levels in response to insulin-induced hypoglycemia in human
subjects. Endocrinology 104:Abstr. 344.
25 . Ipp, E ., J . Rivier, R . E . Dobbs, M . Brown,W. Vale, and R . H . Unger. 1979. Somatostatin
analogs inhibit somatostatin release. Endocrinology. 104:1270-1273 .
26. Iturriza, F . C . 1973 . Autoregulation of the secretion of MSH in incubates of toad pars
intermedia . Gen. Comp. Endocrinof . 20:168-171 .
27. Jacobowitz, D . M ., and T. L . O'Donohue . 1978. aMSH: immunohistochemical identifi-
cation and mapping in neurons of rat brain . Proc. Nail . Acad Sci . U. S. A . 75:6300-6304.
28. Kastin, A. J., A . Arimura, A . V . Schally, andM. C . Miller . 1971 . Mas s action-type direct
feedback control of pituitary release . Nat. New Blot 231 :29-30.
29. Keutmann, H. T ., B. A. Eipper, and R . E . Mains . 1979 . Partial characterization of a
glycoprotein comprising the NH,-terminal regionofmouse tumor cell pro-ACTH/endor-
phin. J . Biol . Chem. 254:9204-9208.
30. Kraicer, J. 1975. Mechanisms involved in the release ofadenohypophyseal hormones . In
The Anterior Pituitary. A. Tixier-Vidal andM. G . Farquhar. Academic Press, Inc., New
York . 213 .
31 . Krieger, D. T. 1978. Plasma lipotropin andendorphin in the human . In Endorphins'78. L.
Graf, M . Palkovits, and A . Z . Ronai, editors. Akademiai Kiado, Budapest. 275-290.
32 . Kreiger, D . T., and A. S. Liotta. 1980. Rat anterior pituitary ACTH, PLPH and /J-
endorphin: parallel synthesis and release. Endocrinology. 106 :Abstr. 309 .
33 . MacGregor, R. R., J . W. Hamilton, G . N. Kent, R . E. Shofstall, and D . V . Cohn, 1978 .
Degradation of proPTH and PTH by parathyroid and liver cathepsin B . J . Biol. Chem.
254:4428-4433 .
34 . Mains, R. E  B . A . Eipper . 1976. Biosynthesi s of ACTH in mouse pituitary tumor cells .
J . Biol. Chem . 251:4115-4120 .
35 . Mains, R. E ., and B. A. Eipper. 1978. Coordinate synthesis of corticotropins and endor-
phinsby mouse pituitary tumor cells . J. Biol. Chem. 253 :651-655 .
36 . Mains, R. E ., and B. A. Eipper. 1979. Synthesis and secretion of corticotropins, melano-
tropins, and endorphins by rat intermediate pituitary cells . J. Biol. Chem. 254 :7885-7894 .
37 . Mains, R . E., and B . A . Eipper . 1980. Biosynthetic studies on ACTH, fl-endorphin, and
a-melanotropin in the rat. Ann. N . Y. Acad. Sci. 343:94-108 .
38 . Mains, R. E ., B . A . Eipper, and N : Ling . 1977 . Common precursor to corticotropins and
endorphins . Proc. Nail. Acad. Sci. U. S. A . 74:3014-3018.
39. Martin, R ., E. Weber, and K . H . Voigt . 1979. Localization of ACTH- and endorphin-
related peptides in the intermediate lobe of the rat pituitary . Cell Tissue Res. 196 :307-319 .
40. Mayer, G. P., J. A. Keaton, 1 . G . Hurst, and J . F. Habener. 1979. Effects of plasma
calcium on the relative proportion ofhormone and C-fragments in parathyroid venous
blood . Endocrinology 104:1778-1784.
41 . Mendelsohn, G ., R. D'Agostino, J. C. Eggleston, and S . B . Bayfn . 1979 . Distribution of
(i-endorphin immunoreactivity in normal human pituitary . J. Clin. Invest. 63:1297-1301 .
28
￿
THE JOURNAL OF CELL BIOLOGY - VOLUME 89, 1981
42 . Mulder, G . H.,and D . T . Krieger. 1979 . ACTHand endorphin/lipotropin are not secreted
concomitantly by human anterior pituitary cells in vitro. Endocrinology. 104 :Abstr. 345.
43 . Nakanishi, S ., A . Inoue, T. Kita, M . Nakamura, A. C. Y . Chang, S. N. Cohen, and S .
Numa. 1979. Nucleotide sequence ofcloned cDNA forbovine ACTH-/?LPH precursor.
Nature (Loud.). 278:423-327.
44. Nilaver, G ., E. A. Zimmerman, R . Defendini, A. S . Liotta, D. T . Krieger, and M. J .
Brownstein. 1979. ACTH and /3LPH in the hypothalamus. J . Cell Biol. 81:50-58 .
45 . Ostlund, R . E ., J. T. Leung, S. V . Hajek, T . Winokur, and M . Melman. 1978. Acute
stimulated hormone release from cultured GH, pituitary cells . Endocrinology . 103 :1245-
1252.
46. Palade,G . E . 1975 . Intracellular aspects ofthe process of protein synthesis . Science(Wash .
D . C) . 189:347-358.
47. Paquette, T. L., E . Herbert, M . Hinman . 1979 . Molecularweight forms of ACTH secreted
by primary cultures ofmouse anterior pituitary. Endocrinology. 104 :1211-1216 .
48. Pelletier, G ., and R. Leclerc . 1979 . Immunohistochemical localization ofACTH in the rat
brain. Endocrinology. 104:1426-1433.
49. Pelletier, G ., R. Puviani, and R. Leclerc. 1979 . Inununoelectron microscopic localization
of ACTH, PLPH, and a fragment (I6K) of their common precursor in rat brain.
Endocrinology. 104 :Abstr. 227.
50. Pernrutt, M. A., and D. M. Kipnis. 1972 . Insulin biosynthesis: On the mechanism of
glucose stimulation . J . Biol. Chem. 247:1194-1199 .
51 . Przewlocki, R ., V . Holl4 K . H. Voigt, and A. Herz. 1979 . Modulation of in vitro release
of/3-endorphin from the separate lobes ofthe rat pituitary . Life Sci . 24:1601-1608 .
52. Raymond, V., 1 . Lepine, J. C . Lissitzky, J. Cote, and F . Labrie . 1979. Parallel release of
ACTH, fl-endorphin, aMSH andSMSH-litre immunoreactivities in rat anterior pituitary
cells in culture . Mol Cell . Endocrinol 16:113-122 .
53. Richardson, U. I. 1978. Self-regulation of ACTH secretion by mouse pituitarytumor cells
in culture . Endocrinology. 102:910-917 .
54. Richardson, U. L, and A. Schonbrunn . 1978 . Somatostatin inhibition ofACTH release in
mouse pituitary cells. Endocrinology. 102 :Abstr. 302 .
55. Sabol, S. 1978. Regulation ofendorphinproductionby glucocorticoids incultured pituitary
tumor cells . Biochem . Biophys. Res . Commun . 82:560-567.
56. Sando, H., and G . M . Grodsky. 1973 . Dynamic synthesis and release of insulin and
proinsulin from perfused islets. Diabetes. 22:354-360 .
57 . Semoff, S ., B . B . Fuller, and M . E. Hadley . 1978 . Secretion ofMSH in long-term cultures
of pituitary neurointermediate lobes. Cell Tissue Res. 194 :55-69.
58. Sharp, G .W . G ., C. Wollheim, W . A . Muller, A . Gutzeit, P. A . Trueheart, B. BlondeL L .
Orci, and A . E . Resold. 1975. Studies on the mechanism of insulin release . Fed . Proc . 34 :
1537-1548.
59. Sheppard, M . S ., J. Kraicer, and J . V. Milligan. 1980 . Mechanisms governing the release
of growth hormone from acutely dispersed purified somatotrophs . In Synthesis and
Release of Adenohypophyseal Hormones. M . Jutisz and K.W. McKems. Plenum Press,
New York. 495-523.
60 . Simantov, R. 1978. Enkephalins, endorphins, and opiate receptors : studies in vitroand in
vivo . In Endorphins '78. L. Graf, M. Palkovits, and A . Z . Ronai, editors. Akademiai
Kiado, Budapest . 221-236 .
61 . Tanaka, K., W. E . Nicholson, and D. N . Orth. 1978 . The nature of the immunoreactive
lipotropins in human plasmaand tissue extracts. J. Clin. Invest. 62 :94-104 .
62 . Taraskevich, P. S ., and W. W. Douglas . 1977 . Action potentials occur in cells of the
normal anterior pituitary gland . Proc . Nail Acad. Sci.U .S .A . 74:4064-4067 .
63 . Trifaro, 1 . M. 1977 . Common mechanisms ofhormone secretion . Annu. Rev. Pharmacol.
Toxical. 17:27-47.
64 . Vale,W., and C . Rivier. 1977 . Substances modulating the secretion ofACTH by cultured
anterior pituitary cells . Fed. Proc. 36:2094-2099 .
65 . Vale, W ., C. Rivier, L . Yang, S. Minick, and R . Guillemin . 1978 . Effects of purified
hypothalamic corticotropin-releasing factor and other substances on secretion of ACTH
and,6-endorphin-like immunoactivities in vitro. Endocrinology. 103:1910-1915.
66. Voigt, K. H ., H. L. Fehm, and R . E. Lang. 1979. The corticotropin-releasing factor in
Brattleboro rats is related to vasopressin .Acta Endocrinol Suppl 225:412 .
67. Watanabe, H., W. E . Nicholson, and D. N . Orth. 1973 . Inhibition of ACTH production
by glucocorticoids in mouse pituitary tumor cells. Endocrinology. 93:411-416 .
68 . Watson, S. J ., H. Akil, C. W. Richards III, and J . D. Barchas. 1978 . Evidence for two
separate opiate peptide neuronal systems . Nature (Land). 275:226-228 .
69. Weber, E., R. Martin, and K .H. Voigt. 1979 .Corticotropin/endorphin precursor: concom-
itantstorage of its fragments in the secretary granules ofanterior pituitary corticotropin/
endorphin cells. Life Sci. 25:1111-1118 .
70. Wiestner, M ., T. Krieg, D. Horlein, R .W. Glanville, P . Fietzek, and P. K. Muller. 1979.
Inhibiting effect of procollagen peptides on collagen biosynthesis in fibroblast cultures.
J. Biol . Chem. 254:7016-7023 .